Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
SHYY-R130-BSTT
Phase 1 small_molecule active
Quick answer
Recombinant oncolytic herpes simplex virus type Ⅰ (R130) for Osteosarcoma is a Phase 1 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shanghai University of Traditional Chinese Medicine
- Indication
- Osteosarcoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active